Form 8-K - Current report:
SEC Accession No. 0001640334-25-000009
Filing Date
2025-01-03
Accepted
2025-01-03 12:48:18
Documents
15
Period of Report
2024-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 24664
  Complete submission text file 0001640334-25-000009.txt   164758

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20241231.xsd EX-101.SCH 6102
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20241231_lab.xml EX-101.LAB 16261
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20241231_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20241231_pre.xml EX-101.PRE 11938
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20241231_def.xml EX-101.DEF 4194
17 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5593
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 25504774
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)